AstraZeneca PLC
AZN
$187.03
-$2.72-1.43%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.68B | 5.72B | 8.18B | 7.11B | 5.40B |
| Total Receivables | 15.17B | 14.30B | 15.15B | 15.17B | 14.82B |
| Inventory | 6.57B | 6.56B | 6.59B | 6.47B | 5.88B |
| Prepaid Expenses | -- | 2.03B | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 203.00M | 112.00M | 12.00M | 195.00M | 45.00M |
| Total Current Assets | 29.61B | 28.72B | 29.94B | 28.94B | 26.14B |
|
|
|||||
| Total Current Assets | 29.61B | 28.72B | 29.94B | 28.94B | 26.14B |
| Net Property, Plant & Equipment | 14.94B | 14.70B | 13.78B | 13.23B | 12.30B |
| Long-term Investments | 21.19B | 21.24B | 21.22B | 21.22B | 21.13B |
| Goodwill | 21.19B | 21.24B | 21.22B | 21.22B | 21.13B |
| Total Other Intangibles | 36.91B | 37.85B | 38.19B | 37.93B | 37.55B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.69B | 9.04B | 9.04B | 8.97B | 7.23B |
| Total Assets | 114.02B | 114.07B | 114.46B | 112.42B | 106.25B |
|
|
|||||
| Total Accounts Payable | 22.51B | 3.82B | 25.03B | 23.99B | 22.54B |
| Total Accrued Expenses | -- | 19.30B | -- | -- | -- |
| Short-term Debt | 3.01B | 644.00M | 1.71B | 2.03B | 1.39B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.05B | 2.92B | 4.87B | 4.92B | 2.39B |
| Total Finance Division Other Current Liabilities | 2.00B | 3.93B | 2.44B | 2.60B | 2.81B |
| Total Other Current Liabilities | 2.00B | 3.93B | 2.44B | 2.60B | 2.81B |
| Total Current Liabilities | 32.57B | 30.62B | 34.05B | 33.54B | 29.13B |
|
|
|||||
| Total Current Liabilities | 32.57B | 30.62B | 34.05B | 33.54B | 29.13B |
| Long-Term Debt | 24.46B | 24.72B | 24.70B | 24.71B | 26.74B |
| Short-term Debt | 3.01B | 644.00M | 1.71B | 2.03B | 1.39B |
| Capital Leases | 1.51B | 1.42B | 1.38B | 1.27B | 1.20B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.09B | 8.60B | 8.35B | 8.09B | 8.06B |
| Total Liabilities | 66.63B | 65.36B | 68.49B | 67.61B | 65.12B |
|
|
|||||
| Common Stock & APIC | 35.66B | 35.65B | 35.63B | 35.63B | 35.62B |
| Retained Earnings | 9.67B | 12.60B | 8.21B | 7.02B | 3.36B |
| Treasury Stock & Other | 2.00B | 414.00M | 2.04B | 2.07B | 2.05B |
| Total Common Equity | 47.33B | 48.67B | 45.89B | 44.72B | 41.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.33B | 48.67B | 45.89B | 44.72B | 41.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 51.00M | 52.00M | 83.00M | 91.00M | 92.00M |
| Total Equity | 47.38B | 48.72B | 45.97B | 44.81B | 41.13B |
|
|
|||||